100 related articles for article (PubMed ID: 20541607)
1. Multiple protein domains determine the cell type-specific nuclear distribution of the catalytic subunit required for apolipoprotein B mRNA editing.
Yang Y; Yang Y; Smith HC
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13075-80. PubMed ID: 9371802
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver.
Blanc V; Park E; Schaefer S; Miller M; Lin Y; Kennedy S; Billing AM; Ben Hamidane H; Graumann J; Mortazavi A; Nadeau JH; Davidson NO
Genome Biol; 2014 Jun; 15(6):R79. PubMed ID: 24946870
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein B knockdown by AAV-delivered shRNA lowers plasma cholesterol in mice.
Koornneef A; Maczuga P; van Logtenstein R; Borel F; Blits B; Ritsema T; van Deventer S; Petry H; Konstantinova P
Mol Ther; 2011 Apr; 19(4):731-40. PubMed ID: 21304496
[TBL] [Abstract][Full Text] [Related]
4. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis.
Miao J; Ling AV; Manthena PV; Gearing ME; Graham MJ; Crooke RM; Croce KJ; Esquejo RM; Clish CB; ; Vicent D; Biddinger SB
Nat Commun; 2015 Apr; 6():6498. PubMed ID: 25849138
[TBL] [Abstract][Full Text] [Related]
5. APOBEC mutagenesis is a common process in normal human small intestine.
Wang Y; Robinson PS; Coorens THH; Moore L; Lee-Six H; Noorani A; Sanders MA; Jung H; Katainen R; Heuschkel R; Brunton-Sim R; Weston R; Read D; Nobbs B; Fitzgerald RC; Saeb-Parsy K; Martincorena I; Campbell PJ; Rushbrook S; Zilbauer M; Buczacki SJA; Stratton MR
Nat Genet; 2023 Feb; 55(2):246-254. PubMed ID: 36702998
[TBL] [Abstract][Full Text] [Related]
6. Mouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1).
Bhattacharya C; Aggarwal S; Kumar M; Ali A; Matin A
PLoS One; 2008 May; 3(5):e2315. PubMed ID: 18509452
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein B Secretion Assay from Primary Hepatocytes.
Wang Y; Li X; Huang R; Chen XW; Wang X
Bio Protoc; 2024 May; 14(9):e4982. PubMed ID: 38737509
[TBL] [Abstract][Full Text] [Related]
8. A1CF Binding to the p65 Interaction Site on NKRF Decreased IFN-β Expression and p65 Phosphorylation (Ser536) in Renal Carcinoma Cells.
Liu Y; Yang J; Weng D; Xie Y
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612387
[TBL] [Abstract][Full Text] [Related]
9. Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer.
Blanc V; Riordan JD; Soleymanjahi S; Nadeau JH; Nalbantoglu I; Xie Y; Molitor EA; Madison BB; Brunt EM; Mills JC; Rubin DC; Ng IO; Ha Y; Roberts LR; Davidson NO
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33445170
[TBL] [Abstract][Full Text] [Related]
10. The Role of RNA Editing in Cancer Development and Metabolic Disorders.
Kung CP; Maggi LB; Weber JD
Front Endocrinol (Lausanne); 2018; 9():762. PubMed ID: 30619092
[TBL] [Abstract][Full Text] [Related]
11. RNA Editors, Cofactors, and mRNA Targets: An Overview of the C-to-U RNA Editing Machinery and Its Implication in Human Disease.
Lerner T; Papavasiliou FN; Pecori R
Genes (Basel); 2018 Dec; 10(1):. PubMed ID: 30591678
[TBL] [Abstract][Full Text] [Related]
12. Exome-wide association study of plasma lipids in >300,000 individuals.
Liu DJ; Peloso GM; Yu H; Butterworth AS; Wang X; Mahajan A; Saleheen D; Emdin C; Alam D; Alves AC; Amouyel P; Di Angelantonio E; Arveiler D; Assimes TL; Auer PL; Baber U; Ballantyne CM; Bang LE; Benn M; Bis JC; Boehnke M; Boerwinkle E; Bork-Jensen J; Bottinger EP; Brandslund I; Brown M; Busonero F; Caulfield MJ; Chambers JC; Chasman DI; Chen YE; Chen YI; Chowdhury R; Christensen C; Chu AY; Connell JM; Cucca F; Cupples LA; Damrauer SM; Davies G; Deary IJ; Dedoussis G; Denny JC; Dominiczak A; Dubé MP; Ebeling T; Eiriksdottir G; Esko T; Farmaki AE; Feitosa MF; Ferrario M; Ferrieres J; Ford I; Fornage M; Franks PW; Frayling TM; Frikke-Schmidt R; Fritsche LG; Frossard P; Fuster V; Ganesh SK; Gao W; Garcia ME; Gieger C; Giulianini F; Goodarzi MO; Grallert H; Grarup N; Groop L; Grove ML; Gudnason V; Hansen T; Harris TB; Hayward C; Hirschhorn JN; Holmen OL; Huffman J; Huo Y; Hveem K; Jabeen S; Jackson AU; Jakobsdottir J; Jarvelin MR; Jensen GB; Jørgensen ME; Jukema JW; Justesen JM; Kamstrup PR; Kanoni S; Karpe F; Kee F; Khera AV; Klarin D; Koistinen HA; Kooner JS; Kooperberg C; Kuulasmaa K; Kuusisto J; Laakso M; Lakka T; Langenberg C; Langsted A; Launer LJ; Lauritzen T; Liewald DCM; Lin LA; Linneberg A; Loos RJF; Lu Y; Lu X; Mägi R; Malarstig A; Manichaikul A; Manning AK; Mäntyselkä P; Marouli E; Masca NGD; Maschio A; Meigs JB; Melander O; Metspalu A; Morris AP; Morrison AC; Mulas A; Müller-Nurasyid M; Munroe PB; Neville MJ; Nielsen JB; Nielsen SF; Nordestgaard BG; Ordovas JM; Mehran R; O'Donnell CJ; Orho-Melander M; Molony CM; Muntendam P; Padmanabhan S; Palmer CNA; Pasko D; Patel AP; Pedersen O; Perola M; Peters A; Pisinger C; Pistis G; Polasek O; Poulter N; Psaty BM; Rader DJ; Rasheed A; Rauramaa R; Reilly DF; Reiner AP; Renström F; Rich SS; Ridker PM; Rioux JD; Robertson NR; Roden DM; Rotter JI; Rudan I; Salomaa V; Samani NJ; Sanna S; Sattar N; Schmidt EM; Scott RA; Sever P; Sevilla RS; Shaffer CM; Sim X; Sivapalaratnam S; Small KS; Smith AV; Smith BH; Somayajula S; Southam L; Spector TD; Speliotes EK; Starr JM; Stirrups KE; Stitziel N; Strauch K; Stringham HM; Surendran P; Tada H; Tall AR; Tang H; Tardif JC; Taylor KD; Trompet S; Tsao PS; Tuomilehto J; Tybjaerg-Hansen A; van Zuydam NR; Varbo A; Varga TV; Virtamo J; Waldenberger M; Wang N; Wareham NJ; Warren HR; Weeke PE; Weinstock J; Wessel J; Wilson JG; Wilson PWF; Xu M; Yaghootkar H; Young R; Zeggini E; Zhang H; Zheng NS; Zhang W; Zhang Y; Zhou W; Zhou Y; Zoledziewska M; ; ; ; ; ; Howson JMM; Danesh J; McCarthy MI; Cowan CA; Abecasis G; Deloukas P; Musunuru K; Willer CJ; Kathiresan S
Nat Genet; 2017 Dec; 49(12):1758-1766. PubMed ID: 29083408
[TBL] [Abstract][Full Text] [Related]
13. APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.
Snyder EM; McCarty C; Mehalow A; Svenson KL; Murray SA; Korstanje R; Braun RE
RNA; 2017 Apr; 23(4):457-465. PubMed ID: 28069890
[TBL] [Abstract][Full Text] [Related]
14. The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions.
Prohaska KM; Bennett RP; Salter JD; Smith HC
Wiley Interdiscip Rev RNA; 2014; 5(4):493-508. PubMed ID: 24664896
[TBL] [Abstract][Full Text] [Related]
15. Metabolic regulation of APOBEC-1 complementation factor trafficking in mouse models of obesity and its positive correlation with the expression of ApoB protein in hepatocytes.
Galloway CA; Ashton J; Sparks JD; Mooney RA; Smith HC
Biochim Biophys Acta; 2010 Nov; 1802(11):976-85. PubMed ID: 20541607
[TBL] [Abstract][Full Text] [Related]
16. Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor.
Lehmann DM; Galloway CA; Sowden MP; Smith HC
Nucleic Acids Res; 2006; 34(11):3299-308. PubMed ID: 16820530
[TBL] [Abstract][Full Text] [Related]
17. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
[TBL] [Abstract][Full Text] [Related]
18. Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.
Blanc V; Navaratnam N; Henderson JO; Anant S; Kennedy S; Jarmuz A; Scott J; Davidson NO
J Biol Chem; 2001 Mar; 276(13):10272-83. PubMed ID: 11134005
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein B: from editosome to proteasome.
Chan L; Chang BH; Liao W; Oka K; Lau PP
Recent Prog Horm Res; 2000; 55():93-125; discussion 126. PubMed ID: 11036935
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
